Chen T Y, Ma H W, Jin R R, Xu C, Hua H J, Song G X, Zhang W M, Zhang Z H
Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Zhonghua Bing Li Xue Za Zhi. 2017 Aug 8;46(8):553-558. doi: 10.3760/cma.j.issn.0529-5807.2017.08.007.
To evaluate the relationship between visceral pleural invasion (VPI) and other clinicopathological features in lung adenocarcinoma with tumor size ≤3 cm, and to investigate the impact of VPI on the patients' prognosis. The clinical and pathological features were retrospectively reviewed in 231 cases of lung adenocarcinoma with the largest diameter of tumor ≤3 cm, following complete resection and systemic lymphadenectomy. VPI was divided into three grades, PL0, PL1 and PL2 according to modified Hammar classification for lung cancer upon elastic fiber staining. Survival analysis was performed by Kaplan-Meier method, and the risk factors for prognosis were explored by Cox proportional hazards model. Patient prognosis was evaluated by progression-free survival (PFS) and overall survival (OS). In all 231 cases, the number of patients with VPI was 70 (30.3%), of which 61 cases were PL1 and 9 cases were PL2. The remaining 161 cases (69.7%) had no VPI (PL0). The tumor size (=0.003), histological grade (<0.01), the presence of solid component (=0.001) and micropapillary component (=0.009), N stage (<0.01) and TNM stage (<0.01) were significantly correlated with VPI. Patients with VPI had significantly shorter PFS and OS than those without VPI (<0.01). There were significant differences in PFS and OS between patients with different VPI levels (<0.01). Cox multivariate regression analysis showed that VPI was not an independent prognostic factor, whereas PL2 was an independent prognostic factor for PFS (=0.007), but not an independent prognostic factor for OS (=0.052). For patients with lung adenocarcinoma of tumor size ≤3 cm, VPI is related to poor prognosis; However, only PL2 is an independent prognostic factor for PFS. It may be not necessary to separate PL0 and PL1 status in smaller lung adenocarcinomas. Therefore, the definition of VPI may need further modification through large cohort studies.
评估肿瘤大小≤3 cm的肺腺癌中脏层胸膜侵犯(VPI)与其他临床病理特征之间的关系,并探讨VPI对患者预后的影响。对231例最大肿瘤直径≤3 cm的肺腺癌患者进行了回顾性临床和病理特征分析,这些患者均接受了完整切除及系统性淋巴结清扫术。根据改良的肺癌哈马尔弹性纤维染色分类法,VPI分为三个等级,即PL0、PL1和PL2。采用Kaplan-Meier法进行生存分析,并通过Cox比例风险模型探讨预后的危险因素。通过无进展生存期(PFS)和总生存期(OS)评估患者预后。在全部231例患者中,VPI患者有70例(30.3%),其中61例为PL1,9例为PL2。其余161例(69.7%)无VPI(PL0)。肿瘤大小(=0.003)、组织学分级(<0.01)、实性成分的存在(=0.001)和微乳头成分(=0.009)、N分期(<0.01)和TNM分期(<0.01)与VPI显著相关。VPI患者的PFS和OS显著短于无VPI患者(<0.01)。不同VPI水平患者的PFS和OS存在显著差异(<0.01)。Cox多因素回归分析显示,VPI不是独立的预后因素,而PL2是PFS的独立预后因素(=0.007),但不是OS的独立预后因素(=0.052)。对于肿瘤大小≤3 cm的肺腺癌患者,VPI与预后不良相关;然而,只有PL2是PFS的独立预后因素。在较小的肺腺癌中,可能没有必要区分PL0和PL1状态定义。因此,VPI的定义可能需要通过大型队列研究进一步修正。